Skip to main content
Back
Watch Compare

BIO-PATH HOLDINGS, INC.

Data quality: 83%
BPTH
OTC Manufacturing Chemicals
$0.06
$0.00 (0.00%)
Mkt Cap: 467,107.0
Price
$0.05
Mkt Cap
467,107.0
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -4.48 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.08
Interest CoverageN/A

Valuation

PE (TTM)
-0.04
Above sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E 0.0 -1.5
P/B — 1.6
ROE % — -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q22025 -$0.40 -$0.55 -37.5%
Q12025 -$0.38 -$0.40 -5.3%
Q42024 -$0.37 -$0.07 +81.1%
Q32024 -$1.02 -$0.70 +31.4%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -11.18 M
ROE N/A ROA -1556.82%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -4.48 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.08
Interest Coverage N/A Asset Turnover N/A
Working Capital -8.02 M Tangible Book Value -8.00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.04 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -958.45%
Market Cap 467,107.0 Enterprise Value 467,107.0
Per Share
EPS (Diluted TTM) -1.14 Revenue / Share N/A
FCF / Share -0.48 OCF / Share -0.48
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 40.05%
SBC-Adj. FCF -4.77 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -9.89 M -16.08 M -13.87 M -10.44 M -10.88 M
EPS (Diluted) -4.12 -33.63 -1.91 -1.55 —
Gross Profit — — — — —
Operating Income -11.99 M -15.84 M -13.90 M -10.44 M -10.91 M
EBITDA — — — — —
R&D Expenses 7.30 M 11.61 M 9.17 M 5.91 M 6.58 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3.88 M 3.22 M 15.97 M 26.57 M 16.48 M
Total Liabilities 3.73 M 2.78 M 1.80 M 1.11 M 1.41 M
Shareholders' Equity 154,000.0 441,000.0 14.17 M 25.46 M 15.07 M
Total Debt — — — — —
Cash & Equivalents — — — — —
Current Assets 3.78 M 3.04 M 15.62 M 26.14 M 15.96 M
Current Liabilities 3.30 M 1.91 M 1.68 M 958,000.0 1.17 M